How to Make Billions from Exposing Fraud | E2234

Quick Overview

The Anti-fraud Company, founded by Alex Sheay and co-founders, monetizes investigative journalism by utilizing the False Claims Act (FCA) to uncover and file lawsuits against government fraud, positioning themselves as the whistleblower to collect 15% to 30% of recovered funds, a model distinct from traditional law firms.

Key Points: The Anti-fraud Company operates without traditional customers, monetizing by acting as the whistleblower under the False Claims Act (FCA) to recover fraud penalties from the government. The FCA allows a whistleblower to receive 15% to 30% of the recovered amount when they file a lawsuit on behalf of the government against a fraudster, often involving defense contractor fraud. Alex Sheay, the engineer co-founder, initially gained attention by analyzing wasteful practices at Brown University, which receives about $500 million annually from federal funding. The scale of potential fraud is massive, with estimates ranging from $500 billion annually (GAO) to $1.5 trillion, compared to the approximately $4 billion recovered under the FCA each year. The company is not a law firm representing whistleblowers; instead, they are 'the whistleblower,' leveraging investigative journalism and AI to find unreported frauds. One co-founder, a former FTC attorney, focuses on fraud within pharma, Medicare, and Medicaid, particularly regulatory capture preventing generics from entering the market.

Context: The discussion centers on a startup called The Anti-fraud Company, founded by Alex Sheay (an engineer) and two lawyer co-founders, which aims to productize the process of uncovering fraud against the US government. This process is enabled by the False Claims Act (FCA), a statute dating back to 1863 designed to combat defense contractor fraud, which grants significant financial rewards to those who bring successful claims on behalf of the government.

Detailed Analysis

The Anti-fraud Company employs a novel business model where they act as the whistleblower, using investigative journalism and AI to identify fraud implicating federal spending, primarily overbilling by corporations. They are not a law firm representing whistleblowers; they are the entity filing the claim under the FCA's qui tam provision, which entitles them to 15% to 30% of recovered funds. Co-founder Alex Sheay's background includes testifying before Congress regarding wasteful spending at Brown University, leading to the realization that the government cannot police all activity effectively. This insight aligns with their co-founder, a former FTC attorney focused on pharmaceutical fraud. The potential market (TAM) for this is enormous, estimated by some to be $1.5 trillion in fraud annually, with current FCA recoveries being only a few billion dollars, indicating massive opportunity for expansion beyond traditional insider whistleblowing, as competitors can also initiate such suits.